https://sputniknews.in/20261107/chinese-scientists-unlock-promising-advance-against-epilepsy-12815571.html
Chinese Scientists Unlock Promising Advance Against Epilepsy
Chinese Scientists Unlock Promising Advance Against Epilepsy
Sputnik India
Chinese scientists have successfully tested an experimental treatment that uses genetic engineering and a drug-activated molecular switch to suppress seizures... 07.11.2026, Sputnik India
2026-11-07T18:19+0530
2026-11-07T18:19+0530
2026-11-07T18:29+0530
science & tech
science & tech
health
china
https://cdn1.img.sputniknews.in/img/07ea/0b/07/12815735_0:211:2047:1362_1920x0_80_0_0_53ec3cdc74a0f1b20f82831ae9f2a1db.jpg
The world's first human trial of this approach could open a new treatment pathway for millions of people with drug-resistant epilepsy, potentially controlling seizures without removing brain tissue.
https://sputniknews.in/20261107/russia-unearths-exceptionally-rare-blue-diamond-12814473.html
china
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
science & tech, health, china
science & tech, health, china
Chinese Scientists Unlock Promising Advance Against Epilepsy
18:19 07.11.2026 (Updated: 18:29 07.11.2026) Chinese scientists have successfully tested an experimental treatment that uses genetic engineering and a drug-activated molecular switch to suppress seizures in patients with drug-resistant epilepsy, according to research published in the New England Journal of Medicine.
Breakthrough results: Three patients aged 28–37 experienced an average 92.6% reduction in seizures just two months after treatment.
How it works: Researchers injected a modified viral vector into the hippocampus, making targeted neurons respond to low doses of clozapine, a drug that suppresses abnormal electrical activity.
Long-lasting effects: Two patients remained seizure-free during extended follow-up, while the third regained seizure control after restarting medication following an interruption.
The world's first human trial of this approach could open a new treatment pathway for millions of people with drug-resistant epilepsy, potentially controlling seizures without removing brain tissue.
